Modified Prostaglandins

Miscellaneous Modified Prostaglandins.—Crabbe et al have outlined the synthesis of four prostanoid [2 + 2] cycloadducts (189)-(192) involving a 

The Upjohn group have outlined the synthesis of 3- and 4-oxa-PG analogues containing a phenyl group in the Cg-chain and proceeding via a bicyclo-[3,1,0]hexan-3-one intermediate.  

---

Research and development of Beraprost sodium, a stable modified prostaglandin PGI2 possessing cyclopenta[d]benzofuran fragment 96YGK1055,97YZ509. 

Finally, Corey reduction was used to solve the particular problem of the diastereoselective reduction of the ketone in C-15 in a prostaglandin synthesis. Corey reported a selectivity of 90 10.39 We have investigated the reduction of a modified prostaglandin and, despite considerable efforts,... 

The reaction to give a 7-methoxybicyclo[3.2,0]heptadien-2-one has been optimised to provide high yields and the product is a valuable starting material for the preparation of a variety of natural and modified prostaglandins [232]. ... 

II. Syntheses of structurally modified prostaglandins - The synthesis of dl-T-oxa-PGEi was reported by J. Fried and his coworkers and followed an... 

Many prostaglandin analogues have been synthesized and subjected to biological testing, and clinical studies have been extended from the earlier work on the natural compounds to the evaluation of modified prostaglandins with greater potency and selectivity of action. 

Also, synthetically modified prostaglandin analogues have been evaluated for potential use as contraceptives. In small amounts they induce abortion. B. Samuelsson and E. J. Corey have made major contributions in the field of characterization and synthesis of prostaglandin derivatives (201). 

Modified prostaglandins (11-deoxy-ll-oxa analogues of prostaglandin 2 and p2 ) have been prepared from standard glycos-... 

II. Syntheses of structiirally modified prostaglandins - In the course of synthesizing prostaglandin analogs with a six-membered ring in place of the usual flve-membered ring, N.S. Crossley ° developed a new synthetic approach which is outlined below. Reduction of readily available diketone gave a mixture of products frcm which crystallized in 24 yield. Conversion of the latter to crystalline aldehyde 20 was performed as indicated. (Epoxide is the major product of an epimeric pair.)... 

Animal cells can modify arachidonic acid and other polyunsaturated fatty acids, in processes often involving cyclization and oxygenation, to produce so-called local hormones that (1) exert their effects at very low concentrations and (2) usually act near their sites of synthesis. These substances include the prostaglandins (PG) (Figure 25.27) as well as thromboxanes (Tx), leukotrienes, and other hydroxyeicosanoic acids. Thromboxanes, discovered in blood platelets (thrombocytes), are cyclic ethers (TxBg is actually a hemiacetal see Figure 25.27) with a hydroxyl group at C-15. 

In addition to its other properties, interest in the potential use of the vasodilative properties of prostaglandin El, alprostadil ( ), has led to several conceptually different syntheses.For this purpose, the classic Corey process has to be modified by reversing the order of addition of the side chains to allow for convenient removal of the unwanted double bond in the upper side chain. For example, Corey lactone is protected with dihydropyran (acid catalysis), reduced to the lactol with diisobutyaluminum hydride, and then subjected to the usual Wittig reaction to give intermediate This is... 

In the preceding chapters, the synaptic pharmacology of those substances clearly established as NTs in the CNS, i.e. glutamate, GABA, ACh, NA, DA, 5-HT and certain peptides, has been discussed in some detail. There are other substances found in the CNS that could have a minor transmitter role, e.g. ATP, histamine and adrenaline, while still others that cannot claim such a property but clearly modify CNS function in some way, e.g. steroids, prostaglandins and nitric oxide. We will consider each of them in what we hope is appropriate detail. 

Scheme 6. Proposed biosynthesis of preelavulone A (30) and prostaglandin A2 (41) from arachidonic acid, modified from Corey and coworkers [57]...

Lin, C.-H., Aristoff, P.A., Johnson, P.D., McGrath, J.P., Timko, J.M., and Robert, A., Benzidine prostaglandins synthesis of optically pure 15-deoxy-U-68,215 and its enantiomer via a modified intramolecular Wadsworth-Emmons-Wittig reaction, /. Org. Chem., 52, 5594, 1987. 

The realization of the widespread occurrence of amino acid radicals in enzyme catalysis is recent and has been documented in several reviews (52-61). Among the catalytically essential redox-active amino acids glycyl [e.g., anaerobic class III ribonucleotide reductase (62) and pyruvate formate lyase (63-65)], tryptophanyl [e.g., cytochrome peroxidase (66-68)], cysteinyl [class I and II ribonucleotide reductase (60)], tyrosyl [e.g., class I ribonucleotide reductase (69-71), photosystem II (72, 73), prostaglandin H synthase (74-78)], and modified tyrosyl [e.g., cytochrome c oxidase (79, 80), galactose oxidase (81), glyoxal oxidase (82)] are the most prevalent. The redox potentials of these protein residues are well within the realm of those achievable by biological oxidants. These redox enzymes have emerged as a distinct class of proteins of considerable interest and research activity. 

The effect of the modifiers appears to be more evident in the case of Ru-MCM-41 catalysts. The size-controlled mesoporous channels of MCM-41 affords a better interaction of the prostaglandin intermediates with modifiers [274,275],... 

---